Pharmacological treatment of depression in patients with a primary brain tumour-Reference-Cited by-同舟云学术

Pharmacological treatment of depression in patients with a primary brain tumour

Published:2013-05-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rooney Alasdair G¹,Grant Robin¹

Affiliation:

1. Western General Hospital; Edinburgh Centre for Neuro-Oncology (ECNO); Crewe Road South Edinburgh Scotland UK EH4 2XU

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006932.pub3/fullpdf

Reference56 articles.

1. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival. The Mayo Clinic experience;Caudill;American Journal of Clinical Oncology,2011

2. Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors;Koval'chuk;Voprosy Onkologii,2007

3. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project;Litofsky;Neurosurgery,2004

4. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients;Meyers;Journal of Clinical Oncology,1998

5. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Programme;Morrow;Journal of Clinical Oncology,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatment of depression in patients with brain tumors;International Journal of Cancer;2024-06-28

2. Rational treatment of depressive syndromes in brain tumor patients;Der Nervenarzt;2023-10-20

3. Antidepressants for the treatment of depression in people with cancer;Cochrane Database of Systematic Reviews;2023-03-31

4. Palliative care in patients with primary brain tumours;Onkologie;2022-11-22

5. Association of antidepressant drug use with outcome of patients with glioblastoma;International Journal of Cancer;2022-11-17